TYRX absorbable antibacterial envelope

Status:: Do Not Prescribe (DNP)
Decision Date:: June 2022

Comments

NICE TA790 - TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)

Black Drug Classifications

2: Have a lack of data on safety compared with standard therapy
5: Less cost-effective than current standard therapy
6: Have NICE guidance that recommends they should not be used